Tamoxifen protects against acute tumor necrosis factor α-induced cardiac injury via improving mitochondrial functions

Yunfeng Zhao, Li Ming Wang, Luksana Chaiswing, Hsiu Chuan Yen, Terry D. Oberley, Yu Chin Lien, Shu Mei Lin, Mark P. Mattson, Daret St. Clair

Research output: Contribution to journalArticlepeer-review

Abstract

Tamoxifen is the most commonly used antiestrogen for the treatment of breast cancer. Several clinical trials demonstrate that tamoxifen reduces the risk of heart disease and osteoporosis. However, the mechanism by which tamoxifen causes cardioprotection is unclear. Because increased levels of tumor necrosis factor α (TNFα) in tissue and/or plasma have been observed in virtually all forms of cardiac injury, we investigated whether tamoxifen prevents cardiac injury in a murine model of acute TNFα challenge. Five- to six-week-old female mice were injected (ip) with tamoxifen at 0.25 mg/kg daily for 3 or 7 days before receiving an injection of TNFα. Ultrastructural examination of cardiac tissues revealed remarkable protection against TNFα-induced mitochondrial damage in tamoxifen pretreated mice. Tamoxifen treatment significantly improved the mitochondrial respiratory function and enhanced superoxide-scavenging activity of mitochondria. These findings reveal a novel mitochondria-mediated mechanism by which tamoxifen exerts its cardiac protection effect against acute TNFα-induced heart injury.

Original languageEnglish (US)
Pages (from-to)1234-1241
Number of pages8
JournalFree Radical Biology and Medicine
Volume40
Issue number7
DOIs
StatePublished - Apr 1 2006
Externally publishedYes

Keywords

  • Cardiac injury
  • Mitochondria
  • Superoxide removal
  • Tamoxifen
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Tamoxifen protects against acute tumor necrosis factor α-induced cardiac injury via improving mitochondrial functions'. Together they form a unique fingerprint.

Cite this